Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio Business: Diagnostic Date completed:
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury